Hybrid Grafts Market Outlook (2022 to 2032)

The global hybrid grafts market is expected to reach a valuation of USD 517.3 Million by the end of 2022, and further expand at a CAGR of 5.20% in 2022 to 2032. As per the report, the market is likely to reach a valuation of USD 858.7 Million by the end of 2032.

Attribute Key Statistics
Global Hybrid Grafts Market Estimated Size (2022E) USD 517.3 Million
Projected Market Valuation (2032F) USD 858.7 Million
Value-based CAGR (2022 to 2032) 5.20%
Collective Value Share: Top 5 Countries (2022E) 51.50%

Hybrid grafts are extensively manufactured for their unique capabilities in the field of surgery worldwide. These products are designed in such a way that they can easily challenge traditional surgical procedures.

Hybrid grafts are set to be used for those patients having a small hamstring auto graft diameter. They enable surgeons to accelerate the overall size of grafts and develop a graft diameter of around 8mm or more.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017 to 2021 Hybrid Grafts Demand Outlook Compared to 2022 to 2032 Forecast

The global hybrid grafts market exhibited a CAGR of approximately 16.6% and reached a valuation of USD 2.96 Million in the global vascular grafts market in 2021.

Demand for hybrid grafts will continue to grow with increasing number of cardiac and vascular surgeries across the globe. With the emergence of technologically advanced methods and instruments, need for minimally invasive procedures is likely to surge at a rapid pace.

Minimally invasive procedures can reduce the physical and economic burden placed on patients by enabling a shorter stay in intensive care units or hospitals. The recovery rate is also faster than that of traditional surgical procedures. Patients who are unable to undergo open surgeries due to complications can easily opt for hybrid graft as it is minimally invasive and less painful.

Prevalence of aortic aneurysms (AAs) has increased in the last two decades owing to growing aging population, increasing number of smokers, implementation of screening programs, and availability of improved diagnostic methods. According to the CDC, in 2019, about 9,904 deaths in the USA occurred due to aortic aneurysms or aortic dissections.

Moreover, peripheral arterial disease (PAD) affects nearly 12%–14% of the general population. Its incidence rises with age, with up to 20% of individuals above the age of 75 suffering from the disease. Some of the major risk factors for PAD include smoking, hyperlipidemia, hypertension, diabetes, and metabolic syndrome.

Males and the elderly are more likely to develop PAD. High level of cholesterol is another crucial factor that may lead to PAD among the geriatric population.

Thus, increasing prevalence of PAD and AAs across the globe is projected to help the global hybrid grafts market to grow at a CAGR of 5.20% during the forecast period from 2022 to 2032.

Hybrid Grafts Market

Why is the Global Hybrid Grafts Market Showcasing Lucrative Growth?

The global hybrid grafts market is set to create new growth opportunities owing to ongoing development of novel thoracic aortic grafts. Increasing burden of chronic diseases is also expected to drive the market in the upcoming decade.

Rising number of health issues such as high cholesterol and blood pressure among the aging population is set to result in aortic aneurysms. Development of aortic aneurysms is projected to make them more vulnerable to contracting diseases, thereby pushing demand for hybrid grafts.

Cases of sudden injuries are also very common among the aging population. Surging prevalence of cancer and cardiovascular diseases is another vital factor that would contribute to the growth.

As per the WHO, about 17.9 million people die every year because of cardiovascular diseases worldwide and nearly 85% of all deaths associated with cardiovascular diseases are due to strokes and heart attacks. Increasing adoption of minimally invasive procedures on the back of enhanced recovery rates and low hospital stays is thus estimated to propel the global hybrid grafts market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which are the Factors Restraining the Demand for Hybrid Grafts?

Graft rejection is considered to be one of the major drawbacks in the global hybrid grafts market. Prevalence of graft rejection is projected to grow at a fast pace as medication management is unable to prevent the same.

High cost of endovascular aneurysm repair treatments is another concern in the global market. Cost of treatment is likely to be unaffordable for a huge percentage of the middle- and lower-middle-class community. Spurred by the aforementioned limitations, demand for hybrid grafts may decline in the forthcoming years.

Country-wise Insights

What Makes the USA a Highly Lucrative Market for Hybrid Grafts?

Key Players Are Developing Thoracic Aortic Grafts in the USA

The USA held approximately 38.2% of the global hybrid grafts market share in 2021. Presence of favourable reimbursement policies and increasing incidence of aortic aneurysm are projected to drive the market in the country.

Further, higher adoption of smoking habits and surging dependence on minimally invasive procedures are contributing to the growth in the United States. Companies in the USA are also focusing on the development of thoracic aortic grafts to meet the ever-increasing demand from patients, which would aid growth.

What is the Germany Hybrid Grafts Market Outlook?

Rising Prevalence of Cardiac and Vascular Diseases to Drive Germany

Germany held a share of about 3.5% in 2021 and is projected to dominate the global hybrid grafts market in the assessment period. Expansion of the healthcare sector, increasing male geriatric population, advancements in minimally invasive procedures, and rising patient pool suffering from cardiac and vascular diseases are anticipated to drive growth.

As per a 2018 study conducted by the German Federal Statistical Office, incidence of thoracic aortic aneurysm repair has grown in Germany. Aneurysms were found in around 48,098 individuals and the age accounted was above 69, with 65.2 percent of the population being male.

Hypertension (74.9%), coronary heart disease (26.2%),peripheral artery disease (particularly abdominal aortic aneurysm, 42.6%), and other heart illnesses (41.6%) were the most common comorbidities that were found in the country.

Increasing number of endovascular repairing procedures that are conducted to combat the prevalence of aneurysm is another significant factor that would create high demand for hybrid grafts in Germany.

How is the China Hybrid Grafts Market Faring?

Hybrid Grafts to Be Used for Endovascular Aneurysm Repair Procedures

China hybrid grafts market is estimated to generate nearly 3.8% of share during the forecast period (2022 to 2032). Ongoing development of the country’s healthcare industry with the addition of innovative products and high patient holding capacity is expected to bode well for the market.

Easy availability of premium quality, yet cost-effective medical instruments in China is also likely to push the market. Increasing number of endovascular aneurysm repair (EVAR) procedures in the country is another vital factor that would aid sales of hybrid grafts.

Moreover, leading Chinese medical device companies are aiming to enter untapped areas for increasing their sales, which would further accelerate growth in the hybrid grafts market in China during the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Which is the Most Preferred Product in the Hybrid Grafts Market?

Thoracic Aortic Grafts to Gain Impetus with Prevalence of Chronic Diseases

Based on product, the thoracic aortic grafts segment is expected to exhibit high growth at a CAGR of 5.6% in the forecast period and hold a share of about 78.2% in the global hybrid grafts market in 2032. Thoracic aortic grafts are gaining traction due to rising prevalence of various chronic diseases with the adoption of unhealthy lifestyles.

Recent developments and modifications in the field of thoracic aortic grafts on the back of changing raw materials and processing techniques are further expected to boost growth of the segment in the global hybrid grafts market.

Which End User Will Dominate the Global Hybrid Grafts Market?

Hospitals to Conduct More Surgical Procedures in Future

Based on end user, hospitals held the highest hybrid grafts market share of 59.2% in 2021. Growing prevalence of cardiac and vascular diseases, as well as increasing number of surgical procedures would drive the segment, thereby propelling sales of hybrid grafts in the evaluation period.

Competitive Landscape

The global hybrid grafts market is moderately fragmented with the presence of various key players. To meet the high consumer demand and expand their customer base, these companies are developing new materials and manufacturing techniques.

Some of the recent industry developments by key players in the hybrid grafts market are given below:

  • In April 2022, Terumo Aortic received the USA Food and Drug Administration (FDA) approval for Thoraflex Hybrid Frozen Elephant Trunk (FET) device for commercial sale in the USA It will be used for the treatment of patients with complex aortic arch disease.
  • In March 2020, CryoLife, Inc., a renowned company focusing on manufacturing new devices associated with cardiac and vascular surgery, received the CE Mark for its E-vita Open NEO. It is a hybrid graft system for the treatment of aortic arch disease.

Scope of the Report

Attribute Details
Estimated Market Size (2022) USD 517.3 Million
Projected Market Valuation (2032) USD 858.7 Million
Value to based CAGR (2022 to 2032) 5.20%
Forecast Period 2022 to 2032
Historical Data Available for 2017 to 2021
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, Egypt, GCC, and South Africa
Key Market Segments Covered Product, End User, and Region
Key Companies Profiled Terumo Corporation; BD Interventional; Getinge AB; Merit Medical Systems, Inc.; JOTEC GmbH
Report Coverage Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives

Hybrid Grafts Market Outlook by Category

By Product:

  • Thoracic Aortic Graft
  • Peripheral Vascular Graft

By End User:

  • Hospitals
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How much was the global hybrid grafts market worth in 2021?

The global hybrid grafts market was worth USD 491.7 Million in 2021 and is set to expand 1.7x over the next ten years.

What is the sales forecast for hybrid grafts market through 2032?

The hybrid grafts market is expected to reach USD 858.7 Million by the end of 2032 and register 5.20% CAGR.

What are the key trends shaping the hybrid graft market?

Growing awareness about minimally invasive procedures, rising geriatric population, risks associated with open surgery, and high prevalence of cardiac & vascular diseases are some of the key trends in the market.

Which are the top 5 countries driving demand for hybrid grafts?

The USA, China, Germany, the UK, and India are expected to drive demand for hybrid grafts.

What is the USA hybrid grafts market outlook?

The USA accounted for about 38.2% of the North America hybrid grafts market share in 2021.

How is the Europe hybrid grafts market faring in Europe?

Europe hybrid grafts market is projected to exhibit growth at a CAGR of 8.1% over the next ten years.

Which countries are the key producers of hybrid grafts?

The USA, Germany, and China are the key producers of hybrid grafts.

Who are the key players in the hybrid grafts market?

Terumo Corporation, BD Interventional, Getinge AB, Merit Medical Systems, Inc., and JOTEC GmbH are some of the key players in the hybrid grafts market.

Table of Content
	1. Executive Summary
	2. Market Overview
	3. Key Market Trends
	4. Key Success Factors
	5. Market Background
	6. Global Hybrid Grafts Demand (in Value or Size in USD Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
	7. Global Hybrid Grafts Market - Pricing Analysis
	8. Global Hybrid Grafts Demand (in Value or Size in USD Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032
	9. Global Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product
		9.1. Thoracic Aortic Graft
		9.2. Peripheral Vascular Graft
	10. Global Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
		10.1. Hospitals
		10.2. Ambulatory Surgical Centers
	11. Global Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
		11.1. North America
		11.2. Latin America
		11.3. Europe
		11.4. South Asia
		11.5. East Asia
		11.6. Oceania
		11.7. Middle East & Africa (MEA)
	12. North America Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	13. Latin America Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	14. Europe Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	15. South Asia Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	16. East Asia Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	17. Oceania Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	18. Middle East and Africa (MEA) Hybrid Grafts Market Analysis 2017 to 2021 and Forecast 2022 to 2032
	19. Market Structure Analysis
	20. Competition Analysis
		20.1. Terumo Corporation
		20.2. BD Interventional
		20.3. Getinge AB
		20.4. Merit Medical Systems, Inc.
		20.5. JOTEC GmbH
	21. Assumptions and Acronyms Used
	22. Research Methodology
Recommendations

Healthcare

Coronary Artery Bypass Graft Market

October 2023

REP-GB-1070

326 pages

Healthcare

Aortic Stents Grafts Market

September 2023

REP-GB-865

215 pages

Healthcare

Thoracic Vascular Stent Grafts Market

July 2023

REP-GB-5926

322 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Hybrid Grafts Market

Schedule a Call